Trevor Allred
Stock Analyst at Oppenheimer
(3.05)
# 1,378
Out of 5,090 analysts
5
Total ratings
100%
Success rate
50.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Trevor Allred
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TBPH Theravance Biopharma | Initiates: Outperform | $27 | $18.55 | +45.55% | 1 | Dec 3, 2025 | |
| MBX MBX Biosciences | Maintains: Outperform | $38 → $80 | $31.97 | +150.23% | 2 | Sep 23, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Outperform | $85 | $100.49 | -15.41% | 1 | Sep 9, 2025 | |
| INVA Innoviva | Initiates: Outperform | $35 | $20.74 | +68.76% | 1 | Aug 11, 2025 |
Theravance Biopharma
Dec 3, 2025
Initiates: Outperform
Price Target: $27
Current: $18.55
Upside: +45.55%
MBX Biosciences
Sep 23, 2025
Maintains: Outperform
Price Target: $38 → $80
Current: $31.97
Upside: +150.23%
Palvella Therapeutics
Sep 9, 2025
Initiates: Outperform
Price Target: $85
Current: $100.49
Upside: -15.41%
Innoviva
Aug 11, 2025
Initiates: Outperform
Price Target: $35
Current: $20.74
Upside: +68.76%